MicroRNA-124 slows down the progression of Huntington’s disease by promoting neurogenesis in the striatum
Tian Liu 1, Wooseok Im 2, Inhee Mook-Jung 1, 3, Manho Kim 2, 4
1 Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea
2 Department of Neurology, Biomedical Research Institute, Seoul National University Hospital, Seoul, South Korea
3 Department of Biochemistry, Seoul National University College of Medicine, Seoul, South Korea
4 Protein Metabolism Medical Research Center, College of Medicine, Seoul National University, Seoul, South Korea
Contact:
Manho Kim, M.D., Ph.D., kimmanho@snu.ac.kr
Supported by:
This study was supported by a grant (A121911 and HI14C2348) of the Korean Health Technology R&D Project, Ministry of Health & Welfare, and National Research Foundation of Korea (NRF) (2011-0012728 and 2014R1A2A1A11051520).
Tian Liu, Wooseok Im, Inhee Mook-Jung, Manho Kim. MicroRNA-124 slows down the progression of Huntington’s disease by promoting neurogenesis in the striatum[J]. Neural Regeneration Research, 2015, 10(5): 786-791.